Identification

Summary

Candida albicans is an extract from Candida albicans used in allergy testing.

Brand Names
Candin
Generic Name
Candida albicans
DrugBank Accession Number
DB10429
Background

Candida albicans is a fungus which can provoke allergic reactions. Candida albicans is used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
Not Available

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
CandidaInjection0.05 g/1mLCutaneous; Intradermal; SubcutaneousAllermed Laboratories, Inc.1974-03-12Not applicableUS flag
Candida albicansInjection, solution0.1 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Candida albicansSolution40000 [PNU]/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Candida albicansInjection, solution20000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Candida AlbicansInjection, solution0.05 g/1mLPercutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Candida AlbicansInjection, solution1000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Candida AlbicansInjection, solution0.10 g/1mLPercutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Candida albicansInjection, solution0.1 g/1mLIntradermal; SubcutaneousAntigen Laboratories, Inc.1992-04-13Not applicableUS flag
Candida albicansSolution0.05 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Candida albicansInjection, solution40000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Mold Mix CCandida albicans (0.1 g/1mL) + Botrytis cinerea (0.1 g/1mL) + Rhodotorula mucilaginosa (0.1 g/1mL) + Trichophyton mentagrophytes (0.1 g/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mold Mix CCandida albicans (0.05 g/1mL) + Botrytis cinerea (0.05 g/1mL) + Rhodotorula mucilaginosa (0.05 g/1mL) + Trichophyton mentagrophytes (0.05 g/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Monilia MixCandida albicans (500 [PNU]/1mL) + Neurospora intermedia (500 [PNU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Monilia MixCandida albicans (0.025 g/1mL) + Neurospora intermedia (0.025 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Monilia MixCandida albicans (10000 [PNU]/1mL) + Neurospora intermedia (10000 [PNU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Monilia MixCandida albicans (0.0005 g/1mL) + Neurospora intermedia (0.0005 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Monilia MixCandida albicans (0.05 g/1mL) + Neurospora intermedia (0.05 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
New Stock Fungi MixCandida albicans (0.003125 g/1mL) + Alternaria alternata (0.003125 g/1mL) + Aspergillus niger var. niger (0.003125 g/1mL) + Aureobasidium pullulans var. pullutans (0.003125 g/1mL) + Botrytis cinerea (0.003125 g/1mL) + Chaetomium globosum (0.003125 g/1mL) + Cladosporium sphaerospermum (0.003125 g/1mL) + Cochliobolus sativus (0.003125 g/1mL) + Epicoccum nigrum (0.003125 g/1mL) + Gibberella fujikuroi (0.003125 g/1mL) + Mucor plumbeus (0.003125 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.003125 g/1mL) + Pleospora betae (0.003125 g/1mL) + Rhizopus stolonifer (0.003125 g/1mL) + Sarocladium strictum (0.003125 g/1mL) + Trichophyton mentagrophytes (0.003125 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
New Stock Fungi MixCandida albicans (0.00625 g/1mL) + Alternaria alternata (0.00625 g/1mL) + Aspergillus niger var. niger (0.00625 g/1mL) + Aureobasidium pullulans var. pullutans (0.00625 g/1mL) + Botrytis cinerea (0.00625 g/1mL) + Chaetomium globosum (0.00625 g/1mL) + Cladosporium sphaerospermum (0.00625 g/1mL) + Cochliobolus sativus (0.00625 g/1mL) + Epicoccum nigrum (0.00625 g/1mL) + Gibberella fujikuroi (0.00625 g/1mL) + Mucor plumbeus (0.00625 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.00625 g/1mL) + Pleospora betae (0.00625 g/1mL) + Rhizopus stolonifer (0.00625 g/1mL) + Sarocladium strictum (0.00625 g/1mL) + Trichophyton mentagrophytes (0.00625 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
New Stock Fungi MixCandida albicans (0.0000625 g/1mL) + Alternaria alternata (0.0000625 g/1mL) + Aspergillus niger var. niger (0.0000625 g/1mL) + Aureobasidium pullulans var. pullutans (0.0000625 g/1mL) + Botrytis cinerea (0.0000625 g/1mL) + Chaetomium globosum (0.0000625 g/1mL) + Cladosporium sphaerospermum (0.0000625 g/1mL) + Cochliobolus sativus (0.0000625 g/1mL) + Epicoccum nigrum (0.0000625 g/1mL) + Gibberella fujikuroi (0.0000625 g/1mL) + Mucor plumbeus (0.0000625 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0000625 g/1mL) + Pleospora betae (0.0000625 g/1mL) + Rhizopus stolonifer (0.0000625 g/1mL) + Sarocladium strictum (0.0000625 g/1mL) + Trichophyton mentagrophytes (0.0000625 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
4D7G21HDBC
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910598
RxNav
1963
Wikipedia
Candida_albicans

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Active Not RecruitingTreatmentCervical Intraepithelial Neoplasia (CIN)1
2CompletedPreventionHuman Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB)2
2CompletedPreventionTuberculosis (TB)1
2CompletedTreatmentHuman Papilloma Virus (HPV) / Verruca (Warts)1
2CompletedTreatmentVerruca (Warts)1
1CompletedNot AvailableHpv / Verruca (Warts)1
1CompletedNot AvailableHuman Papilloma Virus (HPV)1
1CompletedBasic ScienceHealthy Subjects (HS)3
1, 2RecruitingTreatmentHead and Neck Carcinoma1
0CompletedBasic ScienceHealthy Subjects (HS)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
InjectionCutaneous; Intradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.02 g/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionPercutaneous0.10 g/1mL
Injection, solutionSubcutaneous0.01 g/1mL
Injection, solutionSubcutaneous0.02 g/1mL
Injection, solutionSubcutaneous0.1 g/1mL
Injection, solutionSubcutaneous100 [PNU]/1mL
Injection, solutionSubcutaneous1000 [PNU]/1mL
Injection, solutionSubcutaneous10000 [PNU]/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionSubcutaneous40000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.01 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous20000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
Injection, solutionPercutaneous; Subcutaneous1 g/20mL
InjectionCutaneous; Intradermal; Subcutaneous1 g/1000mL
Injection, solutionIntradermal1 U/0.1mL
Injection, solutionSubcutaneous
Injection, solutionIntradermal1000 [PNU]/1mL
Injection, solutionPercutaneous0.1 g/1mL
Injection, solutionPercutaneous; Subcutaneous0.001 g/1mL
Injection, solutionPercutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous
Injection, solutionIntradermal; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53